Lisinopril and Minitran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Minitran (nitroglycerin). Common drug interactions include alopecia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Minitran. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,656 Lisinopril users. Check the latest studies of Lisinopril.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

48 people who take Lisinopril and Minitran together, and have interactions are studied.

Lisinopril and Minitran drug interactions.

What are the common drug interactions of Lisinopril and Minitran, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Balance disorder
  3. Cardiac arrest
  4. Carotid artery aneurysm (a bulging or ballooning in the wall of a blood vessel)
  5. Cellulitis (infection under the skin)
  6. Constipation
  7. Dysphonia (speech disorder attributable to a disorder of phonation)
  8. Hepatic neoplasm (liver tumour)
  9. Loss of consciousness
  10. Oedema (fluid collection in tissue)

male:

  1. Anaemia (lack of blood)
  2. Pleural effusion (water on the lungs)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Asthenia (weakness)
  7. Chronic kidney disease
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Peripheral vascular disorder
  10. Blood cholesterol increased

What are the common drug interactions of Lisinopril and Minitran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Colitis (inflammation of colon)
  2. Death
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

40-49:

n/a

50-59:

  1. Abdominal pain upper
  2. Aortic valve incompetence
  3. Asthma
  4. Cardiac failure congestive
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Costochondritis (chest wall pain)
  7. Depression
  8. Dyspareunia (painful sexual intercourse)
  9. Ejection fraction decreased (systolic heart failure)
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

60+:

  1. Fall
  2. Anaemia (lack of blood)
  3. Confusional state
  4. Insomnia (sleeplessness)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Hypotension (abnormally low blood pressure)
  8. Pain in extremity
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Minitran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Minitran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Minitran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minitran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and nitroglycerin (the active ingredients of Lisinopril and Minitran, respectively), and Lisinopril and Minitran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: